GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » EV-to-FCF

IMGT (XKRX:456570) EV-to-FCF : -11.98 (As of May. 27, 2024)


View and export this data going back to 2023. Start your Free Trial

What is IMGT EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, IMGT's Enterprise Value is ₩53,899.73 Mil. IMGT's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-4,499.74 Mil. Therefore, IMGT's EV-to-FCF for today is -11.98.

The historical rank and industry rank for IMGT's EV-to-FCF or its related term are showing as below:

XKRX:456570' s EV-to-FCF Range Over the Past 10 Years
Min: -24.44   Med: -4.97   Max: -2.6
Current: -11.98

During the past 4 years, the highest EV-to-FCF of IMGT was -2.60. The lowest was -24.44. And the median was -4.97.

XKRX:456570's EV-to-FCF is ranked worse than
100% of 369 companies
in the Biotechnology industry
Industry Median: 8.9 vs XKRX:456570: -11.98

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), IMGT's stock price is ₩12810.00. IMGT's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩832.000. Therefore, IMGT's PE Ratio for today is 15.40.


IMGT EV-to-FCF Historical Data

The historical data trend for IMGT's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT EV-to-FCF Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - - -7.14

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
EV-to-FCF - - - -7.14

Competitive Comparison of IMGT's EV-to-FCF

For the Biotechnology subindustry, IMGT's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMGT's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IMGT's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where IMGT's EV-to-FCF falls into.



IMGT EV-to-FCF Calculation

IMGT's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=53899.725/-4499.738
=-11.98

IMGT's current Enterprise Value is ₩53,899.73 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IMGT's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-4,499.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT  (XKRX:456570) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

IMGT's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12810.00/832.000
=15.40

IMGT's share price for today is ₩12810.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IMGT's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩832.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


IMGT EV-to-FCF Related Terms

Thank you for viewing the detailed overview of IMGT's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT (XKRX:456570) Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines